Figure 5From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining postoperative chemotherapy and surgery compared to surgery alone: mortality at three years. Overall risk ratio = 0.94 (95% CI, 0.74 to 1.18; p = 0.59)Back to article page